Insomnia

Jul 03, 2024

The Rise of Energy Drinks: Power in a Can or a Health Hazard?

Nov 02, 2023

Laborie Medical Acquired Urotronic; Sirtex’s LAVA Liquid Embolic System; Paige’s Cancer Detection in Breast Lymph Nodes; FDA Clearance to Neurovalens’s Non-Invasive Insomnia-Treating Device; Recor Medical’s Renal Denervation System; Pulsecare Medical’s nsPFA Clinical Trial Short-term Follow-up Results

Sep 20, 2023

Sleep Aids Market: Examining Cutting-Edge Technologies and Major Breakthroughs

Jul 28, 2023

Fewer Sleepless Nights Over, Drugs for Insomnia Treatment

May 10, 2022

AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA

Mar 01, 2022

GSK’s Covifenz; Idorsia’s Quviviq; GSK’s ZEJULA; EMA Expands its Nod for BMS, Eli Lilly, and Novartis Drugs; Cantex Secures Global Licence to Develop Azeliragon; Biocon Acquires Viatris’ Biosimilar Business

Apr 14, 2021

Sleep Disorders: An Emerging Public Health Issue

Mar 18, 2019

Narcolepsy now a confirmed Autoimmune Disorder

Feb 26, 2019

Notizia

Newsletter/Whitepaper